Cholesterol-Lowering Atherosclerosis Study (CLAS)

首次发布于 1999 年 10 月 28 日

Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults

计划入组 38 人 · 首次发布于 2020 年 12 月 10 日

Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)

计划入组 500 人 · 首次发布于 1999 年 11 月 4 日

Xla1

LAS-33441

LAS-101057

Universidad de Las Americas

Chile

Universidad de Las Américas

Chile

UNIVERSITY OF NEVADA, LAS VEGAS

United States

SonoThera Demonstrates Novel Ultrasound Gene Delivery for X-Linked Alport Syndrome Treatment

Alport Syndrome Market Projected to Surge at 47% CAGR Through 2036, Fueled by Emerging Disease-Modifying Therapies

FDA Updates Bioresearch Monitoring Technical Specifications for NDAs and BLAs